Brief report: Inadequate description and discussion of enrolled patient characteristics and potential inter-study site differences in reports of randomized controlled trials: A systematic survey in six rheumatology journals

Arthritis and Rheumatology

Volumn 66, Issue 5, 2014, Pages 1395-1399

  Yurdakul, Sebahattin ^a   Mustafa, Bediha Nezhdi ^a   Fresko, Izzet ^a   Seyahi, Emire ^a   Yazici, Hasan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; ARTICLE; HEALTH CARE; HEALTH SURVEY; HUMAN; MEDICAL CARE; MEDICAL INFORMATION; MEDICAL LITERATURE; MULTICENTER STUDY (TOPIC); PATIENT CODING; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATIC DISEASE; RHEUMATOLOGY; SOCIAL STATUS; SYSTEMATIC REVIEW;

DATA COLLECTION; HUMANS; MULTICENTER STUDIES AS TOPIC; PATIENT SELECTION; PERIODICALS AS TOPIC; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 84899766040     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38349     Document Type: Article

References (11)

1. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 637-9.
2. Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-4.
3. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al, CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-94.
4. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332.
5. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials [published erratum appears in BMJ 2011;343:d6131]. BMJ 2010; 340: c869.
6. Mills EJ, Wu P, Gagnier J, Devereaux PJ,. The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp Clin Trials 2005; 26: 480-7.
7. Hill CL, LaValley MP, Felson DT,. Secular changes in the quality of published randomized clinical trials in rheumatology. Arthritis Rheum 2002; 46: 779-84.
8. Rothwell PM,. External validity of randomised controlled trials: to whom do the results of this trial apply? [review]. Lancet 2005; 365: 82-93.
9. Sokka T, Pincus T,. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor α agents in rheumatoid arthritis. Arthritis Rheum 2003; 48: 313-8.
10. Lee SJ, Kavanaugh A,. A need for greater reporting of socioeconomic status and race in clinical trials. Ann Rheum Dis 2004; 63: 1700-1.
11. Callahan LF, Smith WJ, Pincus T,. Self-report questionnaires in five rheumatic diseases: comparisons of health status constructs and associations with formal education level. Arthritis Care Res 1989; 2: 122-31.